Skip to main content

Table 2 Steroid hormone receptor expression in ovarian cancer: rate of expression of the indicated receptors

From: Estrogen receptor β is associated with expression of cancer associated genes and survival in ovarian cancer

  ERα ERβ (nuclear) ERβ (cytoplasmic) PR
All All 121/172 (70.35) 79/167 (45.04) 39/169 (23.08) 55/165 (33.33)
G2 33/47 (70.21) 29/46 (63.04) 12/46 (26.09) 15/47 (31.91)
G3 78/111 (70.27) 45/109 (41.28) 19/109 (17.43) 36/106 (33.96)
FIGO I + II 21/32 (70.54) 12/30 (40.00) 7/31 (22.58) 16/31 (51.61)
FIGO III + IV 79/112 (65.63) 45/100 (45.00) 7/31 (22.58) 31/108 (28.70)
Serous Serous 99/133 (74.44) 59/131 (49.62) 27/131 (20.61) 46/128 (35.94)
G2 23/31 (74.19) 18/31 (58.06) 9/31 (29.03) 11/31 (35.48)
G3 71/97 (73.20) 38/95 (40.00) 17/95 (17.89) 33/92 (35.87)
FIGO I + II 15/20 (75.00) 5/19 (26.32) 6/20 (30.00) 12/19 (63.16)
FIGO III + IV 70/96 (72.92) 45/95 (47.37) 19/92 (20.65) 28/92 (30.43)
  1. Shown are the numbers of positive samples in relation to the total numbers of ovarian cancer cases of the subgroups analysed and the corresponding percentage (in brackets)